ADXBLADDER is a urine-based lab test
delivers a simple, fast and reliable
method of detecting bladder cancer in
those people who have symptoms, such
as haematuria, that lead their doctor to
suspect cancer. The test can also be used
to monitor for the recurrence of bladder
cancer in those patients undergoing follow-up checks.


4 out of 5 of patients are referred to a urologist with suspected bladder cancer because they have blood in their urine, this is called haematuria. Haematuria can be gross haematuria, blood that you can see, or micro haematuria picked up with a dipstick test at your doctors. Other symptoms may include problems such needing to pass urine very often (frequency), needing to pass urine very suddenly (urgency) or pain when passing urine.

If you have any of these symptoms but have not sought medical help, please go see your doctor.

The urologist will use a cystoscope (camera) to look into your bladder for evidence of the cancer, this is a skilled technique and so tests such as ADXBLADDER are used alongside cystoscopy to ensure a confident diagnosis.

For more information on bladder cancer diagnosis and treatment:
This is a link to an external site and is in no way affiliated with Arquer Diagnostics Ltd. This link does not constitute an endorsement of Arquer Diagnostic products


Just void the total contents of your bladder
to give a sample of between 10 and 200mL of
urine, any time of day, this can be processed
and tested by the laboratory.


Its quick and easy to give your sample, peace of
mind has never been so straightforward.


Research indicates that ADXBLADDER can detect
bladder cancer with unprecedented accuracy by
detecting MCM5 protein in cells shed into
the urine by the tumour.

ADXBLADDER is clinically proven to deliver
95% accuracy for the detection of aggressive,
high-grade tumours.

ADXBLADDER is available in a growing number of countries.

ADXBLADDER works by detecting a protein in cancerous bladder cells. To do this the whole contents of the bladder, a “full void” of urine, at any given urination is required.
This sample can be of a volume anywhere up to 200mL (a mug) and as little as 10mL (an egg cup) of urine if that’s what you can produce. It does not matter what time of day you give your sample, although if possible it is best to try to give a sample at least 2 hours after your last urination. For more information on giving a sample for ADXBLADDER testing click here.

Bladder cancer recurrence monitoring

People who have been treated for bladder cancer sometimes develop recurrent tumours. Recurrent bladder cancer tumours occur when  the bladder cancer cells have started to grow again after treatment. 

Some people who are treated for bladder cancer never have a recurrence. Although recurrence is not uncommon among people who are treated for bladder cancer, in many cases the recurrence can be treated effectively. This is especially true for non-invasive bladder cancer that is located in the lining of the bladder (the urothelium) and has not grown into the muscle of the bladder walls.

After your treatment for bladder cancer has ended, your healthcare providers will monitor you regularly during check-ups (also called follow-ups) for signs and symptoms that your bladder cancer may have recurred.¹,² This might involve tests such as physical examinationsurine tests, blood tests, and/or imaging tests.

It is very important to continue visiting your healthcare provider regularly as scheduled for check-ups, especially if you are receiving active surveillance. 


  1. Bladder Cancer Treatment. National Cancer Institute.
    Accessed September 2017.
  2. Living as a Bladder Cancer Survivor. American Cancer Society.
    Accessed September 2017.

Ask your urologist about ADXBLADDER.

For more information on how ADXBLADDER works click here